Search Results

[Gene therapy takes the fear out of severe AADC deficiency].

• Authors : Müller T; Springer Medizin, Neu-Isenburg, Germany.

Subjects: Amino Acid Metabolism, Inborn Errors* ; Aromatic-L-Amino-Acid Decarboxylases*/Aromatic-L-Amino-Acid Decarboxylases*/Aromatic-L-Amino-Acid Decarboxylases*/deficiency ; Genetic Therapy*Aromatic amino acid decarboxylase deficiency

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2024 Feb; Vol. 166 (Suppl 1), pp. 21-22.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Internet

Record details

PI3K(p110α) as a determinant and gene therapy for atrial enlargement in atrial fibrillation.

• Authors : Ezeani M; NanoBiotechnology Laboratory, Central Clinical School, Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, 3004, Australia. .; Prabhu S

Subjects: Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/genetics ; Atrial Fibrillation*/Atrial Fibrillation*/Atrial Fibrillation*/therapy ; Genetic Therapy*

• Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2023 Mar; Vol. 478 (3), pp. 471-490. Date of Electronic Publication: 2022 Jul 28.Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium:

Record details

Telomerase gene therapy: a remission toward cancer.

• Authors : Quazi S; GenLab Biosolutions Private Limited, Bangalore, Karnataka, 560043, India. .; Department of Biomedical Sciences, School of Life Science, Anglia Ruskin University, Cambridge, UK. .

Subjects: Genetic Therapy* ; Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Telomerase*

• Source: Medical oncology (Northwood, London, England) [Med Oncol] 2022 Apr 16; Vol. 39 (6), pp. 105. Date of Electronic Publication: 2022 Apr 16.Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium:

Record details

The "Editors" Take to RAG: Promise of CRISPR/Cas9/rAAV6-Based Gene Therapy for RAG2 Deficiency.

• Authors : Béziat V; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France. .; Imagine Institute, Paris University, Paris, France. .

Subjects: CRISPR-Cas Systems* ; Genetic Therapy*; DNA-Binding Proteins

• Source: Journal of clinical immunology [J Clin Immunol] 2021 Jul; Vol. 41 (5), pp. 849-851. Date of Electronic Publication: 2021 Mar 19.Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Print-Electronic Cited Medium:

Record details

Double VEGF/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes Mellitus.

• Authors : Barć P; Department and Clinic of Vascular, General and Transplantation Surgery, Jan Mikulicz-Radecki Medical University Hospital, Wroclaw Medical University, Wroclaw, Poland.; Antkiewicz M

Subjects: Genetic Therapy* ; Neovascularization, Physiologic*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*therapy

• Source: Journal of cardiovascular translational research [J Cardiovasc Transl Res] 2021 Jun; Vol. 14 (3), pp. 409-415. Date of Electronic Publication: 2020 Sep 01.Publisher: Springer Country of Publication: United States NLM ID: 101468585 Publication Model: Print-Electronic Cited Medium:

Record details

Gene Therapy

• Authors : Robert E. Sobol; Kevin J. Scanlon; Eirik Nestaas

Subjects: Gynecology; BiotechnologyMEDICAL / Gynecology & Obstetrics; SCIENCE / Chemistry / Industrial & Technical; TECHNOLOGY & ENGINEERING / Chemical & Biochemical

Record details

Gene Therapy

• Authors : Kleanthis G. Xanthopoulos

Subjects: Medicine—Research; Biology—Research; CytologyMEDICAL / Research; MEDICAL / Oncology / General; MEDICAL / Genetics

Record details

A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization.

• Authors : Chen J; Department of Ophthalmology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.

Subjects: Genetic Therapy*; Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/*genetics ; Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/Receptors, Vascular Endothelial Growth Factor/*therapeutic use

• Source: Angiogenesis [Angiogenesis] 2021 Feb; Vol. 24 (1), pp. 97-110. Date of Electronic Publication: 2020 Sep 15.Publisher: Springer Country of Publication: Germany NLM ID: 9814575 Publication Model: Print-Electronic Cited Medium:

Record details

The functional characteristics of optogenetic gene therapy for vision restoration.

• Authors : Lindner M; The Nuffield Laboratory of Ophthalmology, Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. .; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. .

Subjects: Genetic Therapy*; Neurons/Neurons/Neurons/*metabolism ; Retina/Retina/Retina/*metabolism

• Source: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2021 Feb; Vol. 78 (4), pp. 1597-1613. Date of Electronic Publication: 2020 Jul 29.Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Print-Electronic Cited Medium:

Record details

Pluripotent stem cell-based gene therapy approach: human de novo synthesized chromosomes.

• Authors : Sinenko SA; Institute of Cytology, Russian Academy of Sciences, 4 Tikhoretsky Ave, St-Petersburg, 194064, Russia. .; Ponomartsev SV

Subjects: Genetic Therapy* ; Stem Cell Transplantation*; Chromosomes, Artificial, Human/Chromosomes, Artificial, Human/Chromosomes, Artificial, Human/*genetics

• Source: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2021 Feb; Vol. 78 (4), pp. 1207-1220. Date of Electronic Publication: 2020 Oct 03.Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Print-Electronic Cited Medium:

Record details